AZZ Inc. CEO David Dingus diagnosed with pancreatic cancer, leadership unchanged AZZ incorporated announced that David H. Dingus, president and CEO of the company has been recently diagnosed with cancer of the pancreas and will begin an aggressive treatment commencing the week of March 4. It is anticipated that during this period of treatment, all day-to-day operations will continue to be conducted by the organization currently in place. Dingus will continue in his role of CEO. Dingus and the senior management team will continue to work with the board to continue to seek out all opportunities for profit enhancement, growth and expansion of the existing businesses and the successful implementation of the Aquilex SRO acquisition should the company receive the anticipated government approval to proceed. The board, senior management and all employees of the company fully support Dingus and wish him high success during this treatment period. Dingus may have a reduced work schedule during certain periods of this treatment, but he is not anticipated to be away for any extended periods of time.